Whole genome sequencing as a ticket to cancer treatment in the Netherlands: Are inequalities in access to molecular diagnostics unfair?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Whole genome sequencing as a ticket to cancer treatment in the Netherlands: Are inequalities in access to molecular diagnostics unfair?

Published:2024-09 Issue: Volume:41 Page:100492
ISSN:2213-5383
Container-title:Journal of Cancer Policy
language:en
Short-container-title:Journal of Cancer Policy

Author:

Smids Jilles^ORCID,Bomhof Charlotte^ORCID,IJzerman Maarten^ORCID,Bunnik Eline

Publisher

Elsevier BV

Reference26 articles.

1. Implementation of precision medicine in healthcare—A European perspective;Stenzinger;J. Intern. Med.,2023

2. Efficacy of larotrectinib in TRK fusion–positive cancers in adults and children.;Drilon;N. Engl. J. Med.,2018

3. Implementation of whole-genome and transcriptome sequencing into clinical cancer care;Cuppen;JCO Precis. Oncol. [Internet].,2022

4. ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe☆;Bayle;Ann. Oncol.,2023

5. GenCOUNSEL Study, Austin JC, Elliott AM. Out-of-pocket and private pay in clinical genetic testing: A scoping review;Grant;Clin. Genet,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP